Health & TechBio

MiLaboratories is the leader in immunome data analysis software with flagship product MiXCR. MiXCR is a top-notch solution to analyze immunology sequencing data. Our software is used in vaccine, cancer, antibodies, and autoimmune diseases drug development pipelines. We provide a secure, scalable, and fast solution that helps thousands of researchers around the globe to discover new drugs and therapies.

Molecule is creating collaborative ecosystems, where stakeholders in drug development can work together to expedite the process of bringing novel therapeutics to patients. They are connecting leading researchers to funding by turning intellectual property and its development into a liquid and easily investable asset.

Speech therapists still assign homework on sheets of paper, because the industry has not yet been digitized. BlubBlub decided to change this by introducing its video app, which triggers sounds and words recorded by children and for children, helping them to practice in their specific language to address their specific speech problem. BlubBlub connects children, therapists and parents on one platform to ensure everyone plays a role in each child's progress.

9amHealth offers complete cardiometabolic care—a first-of-its-kind, whole-body approach to preventing and treating diabetes, obesity, high cholesterol, and hypertension. 9amHealth partners with employers, PBMs and healthplans to provide effective health benefits for those living with chronic conditions. Their members receive personalized care plans, prescription delivery, at-home lab tests, and unlimited specialist access.

‍

Rivia addresses inefficiencies in biopharma clinical trials, where fragmented data and outdated tools hinder the development of new therapies. Their technology offers a real-time, integrated view of data to improve the evaluation of new treatments and trial conduct. Their vision is to become the unified data infrastructure that transforms clinical development lifecycles, bringing new therapies to market more successfully.

IOMED is a solution that helps understand free text from EHRs, letters, etc. to provide better ICD-10 coding and big data insights for hospitals. It uses sophisticated medical NLP and is seamlessly integrated into the existing IT landscape.

Five Lives builds engaging and accessible digital tools for the tracking and improvement of cognitive health. Their mobile app helps prevent and detect dementia years earlier and at a fraction of the cost of current methods, extending quality of life for millions of people through personalized lifestyle improvements.

‍
The Five Lives team is diverse and experienced with proven ability to build and scale world-leading mobile apps. The core team worked together previously at Peak (60M downloads, 5M monthly active users), is led by successful entrepreneurs and has close input from expert scientific advisors.

Five Lives is now available on the AppStore and PlayStore in the UK and in Australia. The launch to wider European markets is planned for Q4 2022.

‍

Medicus converts health data with its cryptic numbers and medical language into a visual experience with easy-to-understand health insights and actionable recommendations. The users simply have to scan their (blood) test reports, answer some questions about their current health status and finally they will receive personalized insights and recommendations. The personal data of users is a 100% private and safely stored (only) on their devices.

Bloom Diagnostics enables anyone to measure blood markers in a few minutes directly at home or at one of their partner locations. Relevant health information is recorded in the Bloom App and evaluated in connection with the blood sample to produce a personalized health report, containing an individual analysis and actionable information. Understandable. Fast. Fully encrypted, so that nobody can access user data without their consent.

ThinkSono has created the world’s first software to diagnose ‘deep vein thrombosis’ (DVT) at the point of care. DVT is caused by a blood clot in the leg and is responsible for 800,000 deaths in Europe and the USA. ThinkSono’s solution can diagnose DVT within one step at 30 times cheaper and 10 times faster than current solutions on the market.

Elephant is a tech startup tackling big problems in global healthcare. They create lightweight, connectable applications that improve access to care and save lives. Elephant works in emerging economies and has partnered with NGOs, governments, and with healthcare professionals around the world with a view to building the future of digital health and personalized, preventative care.

Second Nature is a digital health program, proven to help people change their behaviors and reduce their risk to type 2 diabetes. It solves this issue by introducing a 6-week behavioral change program delivered digitally and supported by mentors and health tracking. Users receive a Second Nature smart scale and an activity tracker to track their health and outcomes. Additionally, they will be matched with a full-time coach, who will guide them through the prevention program and they learn how to prevent diabetes through Second Nature’s online education courses.

hi.health offers people with private health insurance convenient and safe access to health care billing via app or web. Users can easily submit their invoices digitally and hi.health takes care of the further processing, billing and customer service providing a seamless user experience. With the integrated “library” users receive a transparent overview of relevant digital health products and services, that are (partially) covered by their insurance.

hi.health operates at the intersection of digital health, fintech and insurtech. While each of these rapidly growing markets are already exciting by themselves, their combination in one product is unique. The company was founded by Sebastian Gruber and Fredrik Debong in July 2019.

Diagnosia (acquired by Mediately in 2022) is a mobile and web-based app, which helps doctors and other healthcare professionals make the right medication decision. Additionally, the platform serves as a highly-targeted marketing channel for pharmaceutical companies interested in advertising on the platform.

Diagnosia was founded in 2011 by a group of medical doctors, software engineers, and entrepreneurs. Over the years the company has established itself as the market leader for clinical drug information software in Austria with more than 5,000 health professionals and over 50 healthcare facilities using their app.